Teleflex Incorporated (NYSE:TFX) had its price target upped by investment analysts at Jefferies Group LLC to $270.00 in a research note issued on Friday, The Fly reports. The firm presently has a “buy” rating on the medical technology company’s stock. Jefferies Group LLC’s target price indicates a potential upside of 16.00% from the company’s previous close.

Several other equities analysts have also recently weighed in on the stock. Zacks Investment Research upgraded shares of Teleflex from a “hold” rating to a “buy” rating and set a $228.00 price objective on the stock in a research note on Friday, June 23rd. Barclays PLC reiterated a “buy” rating on shares of Teleflex in a research note on Monday, June 26th. Morgan Stanley upgraded shares of Teleflex from an “equal weight” rating to an “overweight” rating and increased their price objective for the stock from $220.00 to $274.00 in a research note on Wednesday. Leerink Swann increased their price objective on shares of Teleflex from $215.00 to $220.00 and gave the stock a “market perform” rating in a research note on Friday, June 9th. Finally, Deutsche Bank AG reiterated a “buy” rating and issued a $238.00 price objective (up previously from $220.00) on shares of Teleflex in a research note on Wednesday, August 9th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating and eight have assigned a buy rating to the stock. The company has an average rating of “Buy” and an average price target of $239.43.

Shares of Teleflex (TFX) traded up 2.47% during mid-day trading on Friday, reaching $232.75. 539,406 shares of the company’s stock traded hands. Teleflex has a 12-month low of $136.53 and a 12-month high of $235.18. The firm’s 50 day moving average price is $211.09 and its 200-day moving average price is $202.34. The stock has a market cap of $10.48 billion, a price-to-earnings ratio of 44.51 and a beta of 1.05.

Teleflex (NYSE:TFX) last issued its quarterly earnings data on Thursday, August 3rd. The medical technology company reported $2.04 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $1.91 by $0.13. Teleflex had a net margin of 12.36% and a return on equity of 16.12%. The firm had revenue of $528.60 million for the quarter, compared to analysts’ expectations of $518.98 million. During the same quarter in the prior year, the business earned $1.89 EPS. The business’s quarterly revenue was up 11.6% on a year-over-year basis. Equities research analysts forecast that Teleflex will post $8.28 earnings per share for the current year.

COPYRIGHT VIOLATION NOTICE: This article was first posted by American Banking News and is the sole property of of American Banking News. If you are viewing this article on another publication, it was stolen and reposted in violation of US and international copyright law. The original version of this article can be viewed at https://www.americanbankingnews.com/2017/09/08/teleflex-incorporated-tfx-price-target-raised-to-270-00.html.

In related news, Director Stephen K. M.D. Klasko sold 200 shares of the stock in a transaction that occurred on Friday, September 1st. The shares were sold at an average price of $211.75, for a total value of $42,350.00. Following the completion of the sale, the director now directly owns 8,080 shares of the company’s stock, valued at approximately $1,710,940. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gretchen R. Haggerty bought 1,000 shares of Teleflex stock in a transaction that occurred on Wednesday, June 21st. The stock was purchased at an average cost of $203.82 per share, with a total value of $203,820.00. Following the completion of the acquisition, the director now directly owns 1,760 shares in the company, valued at approximately $358,723.20. The disclosure for this purchase can be found here. Insiders sold a total of 600 shares of company stock valued at $125,652 over the last three months. 2.39% of the stock is currently owned by insiders.

A number of institutional investors have recently added to or reduced their stakes in the stock. Neuberger Berman Group LLC increased its holdings in Teleflex by 0.5% in the 2nd quarter. Neuberger Berman Group LLC now owns 5,708 shares of the medical technology company’s stock worth $1,186,000 after acquiring an additional 28 shares in the last quarter. Stifel Financial Corp increased its holdings in Teleflex by 0.6% in the 2nd quarter. Stifel Financial Corp now owns 5,399 shares of the medical technology company’s stock worth $1,121,000 after acquiring an additional 31 shares in the last quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. increased its holdings in Teleflex by 0.6% in the 1st quarter. Mitsubishi UFJ Kokusai Asset Management Co. Ltd. now owns 6,553 shares of the medical technology company’s stock worth $1,270,000 after acquiring an additional 37 shares in the last quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS increased its holdings in Teleflex by 0.6% in the 1st quarter. Commonwealth of Pennsylvania Public School Empls Retrmt SYS now owns 6,560 shares of the medical technology company’s stock worth $1,271,000 after acquiring an additional 38 shares in the last quarter. Finally, Toronto Dominion Bank increased its holdings in Teleflex by 14.5% in the 2nd quarter. Toronto Dominion Bank now owns 552 shares of the medical technology company’s stock worth $115,000 after acquiring an additional 70 shares in the last quarter. 90.50% of the stock is owned by institutional investors.

About Teleflex

Teleflex Incorporated is a provider of medical technology products. The Company designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through six segments: Vascular North America; Anesthesia North America; Surgical North America; Europe, the Middle East and Africa (EMEA); Asia, and Original Equipment Manufacturer (OEM).

The Fly

Analyst Recommendations for Teleflex (NYSE:TFX)

Receive News & Ratings for Teleflex Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Teleflex Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.